Key result
Point-of-care hs-cTn assays accelerate clinical decision-making if key analytical challenges are properly managed.
No takes yet. Share an insight, caveat, or question.
High-sensitivity point-of-care cardiac troponin assays have the potential to accelerate testing in hospital and other healthcare settings, though successful implementation requires addressing specific pre-analytical and analytical issues.
Cullen et al. (2025) conducted a review in Cardiac troponin testing. High-sensitivity cardiac troponin (hs-cTn) point-of-care (POC) assays was evaluated. High-sensitivity cardiac troponin point-of-care assays can accelerate testing across healthcare settings, provided unique pre-analytical and analytical issues are addressed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: